BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2763031)

  • 1. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis.
    Comerota AJ; Stewart GJ; Alburger PD; Smalley K; White JV
    Surgery; 1989 Aug; 106(2):301-8: discussion 308-9. PubMed ID: 2763031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations.
    J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous tone regulatory mechanisms: what's new?
    Comerota AJ; Stewart GJ
    Int Angiol; 1995 Sep; 14(3 Suppl 1):1-7. PubMed ID: 8919256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation of impedance plethysmography in assessing efficacy of dihydroergotamine-heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Parno J; Singer JM
    Thromb Res; 1985 Feb; 37(3):449-58. PubMed ID: 3887636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the Multicenter Trial Committee report: a prospective, randomized study on the prophylaxis of postoperative deep venous thrombosis.
    Comerota AJ
    Pharmacotherapy; 1986; 6(4 Pt 2):18S-22S. PubMed ID: 3534803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
    Kakkar VV; Stamatakis JD; Bentley PG; Lawrence D; de Haas HA; Ward VP
    JAMA; 1979 Jan; 241(1):39-42. PubMed ID: 758493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.
    Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ
    Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement.
    Rocha E; Alfaro MJ; Páramo JA; Cañadell JM
    Thromb Haemost; 1988 Feb; 59(1):93-5. PubMed ID: 3363536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
    Sagar S; Nairn D; Stamatakis JD; Maffei FH; Higgins AF; Thomas DP; Kakkar VV
    Lancet; 1976 May; 1(7970):1151-4. PubMed ID: 58199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
    Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
    Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
    Baumgartner A; Jacot N; Moser G; Krähenbühl B
    Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or knee replacement.
    Stewart GJ; Lachman JW; Alburger PD; Ziskin MC; Philips CM; Jensen K
    Ultrasound Med Biol; 1990; 16(2):133-40. PubMed ID: 2183460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of deep vein thrombosis after major abdominal surgery. Comparison between dihydroergotamine-heparin and intermittent pneumatic calf compression and evaluation of added graduated static compression.
    Mellbring G; Palmér K
    Acta Chir Scand; 1986 Oct; 152():597-600. PubMed ID: 3544626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS; Brill-Edwards P; Panju A; Patel A; McGinnis J; Smith F; Dale I; Johnston M; Ofosu F
    Thromb Haemost; 1995 Aug; 74(2):602-5. PubMed ID: 8584991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusted subcutaneous heparin versus heparin plus dihydroergotamine in prevention of deep vein thrombosis after total hip arthroplasty.
    Leyvraz P; Bachmann F; Vuilleumier B; Berthet S; Bohnet J; Haller E
    J Arthroplasty; 1988; 3(1):81-6. PubMed ID: 3361324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of compression ultrasonography and fibrinogen-related parameters for the detection of postoperative deep vein thrombosis following elective hip replacement: a pilot study.
    Crippa L; Ravasi F; D'Angelo SV; Varagona R; Milani E; Safa O; Tessari L; D'Angelo A
    Thromb Haemost; 1995 Nov; 74(5):1235-9. PubMed ID: 8607101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.